{"id":19410,"date":"2024-04-26T14:40:18","date_gmt":"2024-04-26T14:40:18","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/doc-acquisisce-muscoril-da-sanofi\/"},"modified":"2024-04-28T15:13:12","modified_gmt":"2024-04-28T15:13:12","slug":"doc-acquisisce-muscoril-da-sanofi","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/","title":{"rendered":"Doc acquires Muscoril from Sanofi"},"content":{"rendered":"

DOC, an Italian pharmaceutical company active in the market of branded and equivalent products, announced the agreement for the acquisition of Muscori<\/strong>l, a drug with a muscle relaxant action, marketed by Sanofi, for Italy, Portugal and the Czech Republic.<\/p>\n

\n
\n
\n
\n
\n
\n
\n
\n

The transaction, supported by the shareholders of DOC, TPG and ICG<\/strong>, will further strengthen DOC’s position in the market, confirming the company’s commitment to improving health through effective and accessible treatments. Muscoril will also increase DOC’s existing product line, already packed with over 250 molecules in various therapeutic areas and approximately 700 SKUs covering all major therapeutic areas.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
\n
\n
\n
\n

The signing of this agreement represents an important step forward for DOC in our expansion journey into the Italian market. Muscoril not only enhances our current portfolio, but aligns perfectly with our growth strategy in both the branded and co-branded markets. Operations like this allow us to build a solid and resilient platform, capable of supporting our future growth.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/blockquote>\n

\n
\n
\n
\n
\n
\n

Riccardo Zagaria, DOC Ceo<\/strong><\/em><\/p>\n

Karthic Jayaraman<\/strong>, partner at TPG, added: \u201cSigning the Muscoril acquisition demonstrates DOC’s ability to recognize valuable assets and create an integrated platform to improve care through access to essential, high-quality treatments . This transaction will strengthen DOC’s role as a trusted partner for doctors, pharmacists and patients. We are proud to support the company in its continued expansion.”<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

Thanks to its proven effectiveness, Muscoril has established itself as one of the leading brands among muscle relaxant drugs in Italy. The product is available in different pharmaceutical forms, including orodispersible tablets, capsules and injectable solutions, thus offering patients different treatment options.<\/p>\n","protected":false},"excerpt":{"rendered":"

DOC ha annunciato di aver firmato un accordo per l’acquisizione di Muscoril, farmaco commercializzato da Sanofi per l’Italia, il Portogallo e la Repubblica Ceca<\/p>\n","protected":false},"author":32,"featured_media":19409,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[796],"tags":[],"class_list":{"0":"post-19410","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-market"},"yoast_head":"\nDoc acquisisce Muscoril da Sanofi<\/title>\n<meta name=\"description\" content=\"DOC ha annunciato di aver firmato un accordo per l'acquisizione di Muscoril per l'Italia, il Portogallo e la Repubblica Ceca\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Doc acquisisce Muscoril da Sanofi\" \/>\n<meta property=\"og:description\" content=\"DOC ha annunciato di aver firmato un accordo per l'acquisizione di Muscoril per l'Italia, il Portogallo e la Repubblica Ceca\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-26T14:40:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-28T15:13:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1027\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\"},\"headline\":\"Doc acquires Muscoril from Sanofi\",\"datePublished\":\"2024-04-26T14:40:18+00:00\",\"dateModified\":\"2024-04-28T15:13:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/\"},\"wordCount\":267,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg\",\"articleSection\":[\"Market\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/\",\"name\":\"Doc acquisisce Muscoril da Sanofi\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg\",\"datePublished\":\"2024-04-26T14:40:18+00:00\",\"dateModified\":\"2024-04-28T15:13:12+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\"},\"description\":\"DOC ha annunciato di aver firmato un accordo per l'acquisizione di Muscoril per l'Italia, il Portogallo e la Repubblica Ceca\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg\",\"width\":2560,\"height\":1027,\"caption\":\"Two businessmen shaking hands in office; panoramic banner\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Doc acquires Muscoril from Sanofi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Doc acquisisce Muscoril da Sanofi","description":"DOC ha annunciato di aver firmato un accordo per l'acquisizione di Muscoril per l'Italia, il Portogallo e la Repubblica Ceca","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/","og_locale":"en_US","og_type":"article","og_title":"Doc acquisisce Muscoril da Sanofi","og_description":"DOC ha annunciato di aver firmato un accordo per l'acquisizione di Muscoril per l'Italia, il Portogallo e la Repubblica Ceca","og_url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2024-04-26T14:40:18+00:00","article_modified_time":"2024-04-28T15:13:12+00:00","og_image":[{"width":2560,"height":1027,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg","type":"image\/jpeg"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b"},"headline":"Doc acquires Muscoril from Sanofi","datePublished":"2024-04-26T14:40:18+00:00","dateModified":"2024-04-28T15:13:12+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/"},"wordCount":267,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg","articleSection":["Market"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/","url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/","name":"Doc acquisisce Muscoril da Sanofi","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg","datePublished":"2024-04-26T14:40:18+00:00","dateModified":"2024-04-28T15:13:12+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b"},"description":"DOC ha annunciato di aver firmato un accordo per l'acquisizione di Muscoril per l'Italia, il Portogallo e la Repubblica Ceca","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/04\/AdobeStock_417301150-scaled.jpeg","width":2560,"height":1027,"caption":"Two businessmen shaking hands in office; panoramic banner"},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/doc-acquisisce-muscoril-da-sanofi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"Doc acquires Muscoril from Sanofi"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/19410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=19410"}],"version-history":[{"count":3,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/19410\/revisions"}],"predecessor-version":[{"id":19413,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/19410\/revisions\/19413"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/19409"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=19410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=19410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=19410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}